Baricitinib for rheumatoid arthritis

Natalia V. Zamora; Jean H. Tayar; Maria Angeles Lopez-Olivo; Robin Christensen; Maria E. Suarez-Almazor

doi:10.1002/14651858.CD013311

Baricitinib for rheumatoid arthritis

Natalia V. Zamora, Jean H. Tayar, Maria Angeles Lopez-Olivo, Robin Christensen, Maria E. Suarez-Almazor

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of baricitinib for rheumatoid arthritis.

Original language	English (US)
Article number	CD013311
Journal	Cochrane Database of Systematic Reviews
Volume	2019
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD013311
State	Published - Apr 15 2019

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD013311

Cite this

@article{fe21828ed159415cbe2537eb49ddc623,

title = "Baricitinib for rheumatoid arthritis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of baricitinib for rheumatoid arthritis.",

author = "Zamora, {Natalia V.} and Tayar, {Jean H.} and Lopez-Olivo, {Maria Angeles} and Robin Christensen and Suarez-Almazor, {Maria E.}",

note = "Publisher Copyright: {\textcopyright} 2019 The Cochrane Collaboration.",

year = "2019",

month = apr,

day = "15",

doi = "10.1002/14651858.CD013311",

language = "English (US)",

volume = "2019",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Baricitinib for rheumatoid arthritis

AU - Zamora, Natalia V.

AU - Tayar, Jean H.

AU - Lopez-Olivo, Maria Angeles

AU - Christensen, Robin

AU - Suarez-Almazor, Maria E.

PY - 2019/4/15

Y1 - 2019/4/15

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of baricitinib for rheumatoid arthritis.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of baricitinib for rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=85064469301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064469301&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013311

DO - 10.1002/14651858.CD013311

M3 - Article

AN - SCOPUS:85064469301

SN - 1465-1858

VL - 2019

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD013311

ER -

Baricitinib for rheumatoid arthritis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this